Location History:
- San Mateo, CA (US) (1997 - 1999)
- Palo Alto, CA (US) (2002)
Company Filing History:
5 out of 88 
2 out of 236 
1 out of 23 Years Active: 1997-2002
Title: Inventor Stephen D. Yanofsky: A Pioneer in Peptide Research
Introduction
Stephen D. Yanofsky, based in San Mateo, CA, is a distinguished inventor with a notable portfolio of six patents. His work primarily revolves around the development of innovative peptides and compounds that have significant applications in medical science.
Latest Patents
Among his recent patents, Yanofsky has focused on antagonists of follicle-stimulating hormone activity and peptides that bind to the interleukin-1 type I receptor (IL-1RtI). These peptides are particularly crucial as they can be used to assay the amount of IL-1R, along with their agonists or antagonists, in various samples. His patents detail specific sequences of amino acids, showcasing a sophisticated understanding of peptide interactions and their potential therapeutic uses.
Career Highlights
Yanofsky has made significant contributions during his tenure at notable companies such as Affymax Technologies and Hoechst Marion Roussel. His work there helped propel advancements in the pharmaceutical industry, specifically in peptide therapeutics, establishing him as a noteworthy figure in his field.
Collaborations
Throughout his career, Yanofsky has collaborated with esteemed colleagues, including Ronald W. Barrett and David N. Baldwin. These partnerships have enriched his research and have spurred innovative developments in peptide applications, reflecting the importance of teamwork in scientific advancements.
Conclusion
Stephen D. Yanofsky's contributions to peptide research are exemplified by his patents and his collaborations. His work continues to influence the medical field, paving the way for new therapeutic possibilities and innovations. As the landscape of peptide research evolves, Yanofsky remains a key player in driving progress and fostering future innovations.